Summaries of the Section H (HML) update

Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.

This update summary includes a preview of the changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.

The full Update will be available as a PDF on our website(external link). The changes will be published in the online HML around the 23^rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

18 May 2023 - preview of changes for June 2023

Pharmaceutical	Change
Amino acid formula (without phenylalanine) (PKU GMPro Ultra Lemonade) powder 20 g protein, 4.9 g carbohydrate per 33.4 g sachet	new listing (p’code 2657201) to be delisted 1 December 2023
Atenolol tab 50 mg	Viatris – PSS added Mylan Atenolol – removal of PSS
Copper tab 2.5 mg, chelated	new listing
Diatrizoate meglumine with sodium amidotrizoate oral liq 660 mg per ml with sodium amidotrizoate 100 mg per ml, 100 ml bottle (Gastrografin) inj 260 mg with sodium amidotrizoate 40 mg per ml, 250 ml bottle (Urografin)	price increase
Efavirenz with emtricitabine and tenofovir disoproxil (Mylan) tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg	to be delisted 1 December 2023
Emtricitabine with tenofovir disoproxil tab 200 mg with tenofovir disoproxil 245 mg (300 mg as a maleate)	Tenofovir Disoproxil Emtricitabine Viatris –PSS added Tenofovir Disoproxil Emtricitabine Mylan - removal of PSS
Eptifibatide (Integrilin) inj 2 mg per ml, 10 ml vial inj 750 mcg per ml, 100 ml vial	delisted 1 June 2023
Exemestane (Pfizer Exemestane) tab 25 mg	price decrease and addition of PSS
Iodixanol (Visipaque) inj 270 mg per ml (iodine equivalent), 50 ml bottle and 100 ml bottle inj 320 mg per ml (iodine equivalent), 50 ml bottle, 100 ml bottle and 200 ml bottle	price increase
Iohexol (Omnipaque) inj 240 mg per ml (iodine equivalent), 50 ml bottle inj 300 mg per ml (iodine equivalent), 20 ml bottle, 50 ml bottle and 100 ml bottle inj 350 mg per ml (iodine equivalent), 50 ml bottle, 75 ml bottle, 100 ml bottle, 200 ml bottle inj 350 mg per ml, 500 ml bottle	price increase
Lacosamide (Vimpat) tab 50 mg tab 100 mg tab 150 mg tab 200 mg inj 10 mg per ml, 20 ml vial	amended restriction criteria
Meglumine iotroxate (Biliscopin) inj 105 mg per ml, 100 ml bottle	price increase
Metformin hydrochloride (Viatris) tab 850 mg	new listing (p’code 2628058)
Nicotine gum 2 mg, 384 pack (Habitrol (Fruit)) and (Habitrol (Mint)) gum 4 mg, 384 pack (Habitrol (Fruit)) and (Habitrol (Mint))	to be delisted 1 December 2023
Prednisolone sodium phosphate (Minims Prednisolone) eye drops 0.5%, single dose (preservative free)	price increase
Sirolimus (Rapamune) tab 1 mg tab 2 mg oral liq 1 mg per ml	amended restriction criteria
Sodium fusidate [fusidic acid] (Fucidin) tab 250 mg	price increase
Solifenacin tab 5 mg and 10 mg	Solifenacin Viatris – PSS added Solifenacin Mylan – removal of PSS and to be delisted 1 December 2023
Stiripentol (Diacomit) cap 250 mg and powder for oral liq 250 mg sachet	amended restriction criteria
Valganciclovir (Valganciclovir Viatris) tab 450 mg	new listing (p’code 2635682)
Vitamin B complex (Bplex) tab strong, BPC	price increase
Zinc and castor oil oint, 500 g	Brand change Evara – new listing and addition of PSS (p’code 2658399) Boucher – to be delisted 1 November 2023
Zoledronic acid 4 mg per 5 ml, vial	Zoledronic acid Viatris – PSS added Zoledronic acid Mylan – removal of PSS

Find previous months' summaries